Dennis Hom compensation by year
Sagimet Biosciences Summary Compensation Table · all 2 fiscal years held| Component | FY2022 | FY2023 |
|---|---|---|
| Salary | $357,473 | $226,069 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $0 | $0 |
| Non-equity incentive | $109,351 | — |
| Pension and deferred compensation | $0 | $0 |
| All other | $68 | $519,438 |
| Total | $466,892 | $745,507 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sagimet Biosciences Inc. DEF 14A filed April 18, 2024, accession 0001104659-24-048534, and prior-year filings.
How this page was built: the Sagimet Biosciences Inc. filed document, accession 0001104659-24-048534. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2024.
Sagimet Biosciences’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| David Happel | President and Chief Executive Officer | $2,685,917 |
| Eduardo Martins | Chief Medical Officer | $1,509,081 |
| George Kemble | Executive Chairman and former President, Chief Executive Officer and Chief Scientific Officer | $930,223 |
| Dennis Hom · this page | Former Chief Financial Officer | $745,507 |
The full Sagimet Biosciences compensation record
free company briefThis page is one person within Sagimet Biosciences's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sagimet Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.